Tunisia Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and in Senegal respectively respond to increased international demand and desires of expansion in the African market. MédiS has built up…
Tunisia Habib Toumi, CEO of the Tunisian National Social Security Fund (CNSS), discusses implementing universal healthcare coverage, restoring the financial equilibrium of the fund, and managing the continuous improvement of services provided in the CNSS policlinics. Can you describe the operational characteristics of the Tunisian National Social Security Fund (CNSS)? “Concerning…
Tunisia Khalil Ben Ammar, managing director of Adwya since 2016, has been responsible for stabilizing the finances and corporate atmosphere within the company. In this interview he elaborates on the company’s leading position in the Tunisian market, its transformative environment and the exciting development plans aimed at Africa that Adwya is…
Tunisia Ramzi Sandi, general manager of the Arab Society of Pharmaceutical Industries (SAIPH) is responsible for the development of the company since 2015. From that date, SAIPH has been the strongest performing actor in the Tunisian market with an annual growth of 20 percent in 2016 and 2017. In this interview…
Tunisia Hammadi Ayadi, CEO of Sidi Thabet BiotechPole, proudly introduces the launch of the site’s incubator and announces the soon-to-come opening of the company cluster. This will provide a platform for the fusion of theoretical research and technical knowhow and aid the development of the first biotech drug made in Tunisia…
Tunisia Sara Masmoudi, general manager at Teriak, one of Tunisia’s top three pharmaceutical companies, sums up the evolution the company has undergone since she took over its direction in 2003 at age 32. She also talks about the recent acquisition Teriak has made of Cinpharm, a Cameroonian manufacturer, in line with…
Tunisia Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes is the second largest cause of death in Tunisia”. Moez Lindhallah Mokadem, director of Pharmacie Centrale de Tunisie (PCT), adds…
Tunisia Ridha Charfeddine, founding CEO of Unimed and president of the National Chamber of the Pharmaceutical Industry (CNIP) discusses enforcing European quality standards in Tunisia, the CNIP’s role in guiding pharmaceutical and medical device companies in Tunisia, as well as his entrepreneurial journey with Unimed, now the preferred partner of the…
Tunisia Ramzi Lebbi, general director and co-founder of mc PHARMA, a Tunisian medical information and promotion agency, describes the company’s evolution since its foundation 15 years ago, its service provider activities for multinational companies, and the potential expansion of its portfolio of services. Mr. Lebbi, looking back at mc PHARMA’s creation,…
Tunisia Ali Achouri of Laboratoires Generika in Tunisia discusses his success story, his attentiveness to the satisfaction of its customers, the importance of geographical and cultural proximity with pharmaceutical companies in Maghreb, and how Generika will soon offer its services for the production of inhalable dosage forms as well as various…
Tunisia Walid Lakhdar, country business unit head for Tunisia and Libya at Pfizer, stresses the company’s ongoing dedication to patients in Tunisia. This was illustrated by the significant investments Pfizer has made in Tunisia after the revolution and still continues to make. Lakhdar talks about Pfizer’s successful partnerships in the country…
Tunisia Hechmi Louzir, general manager of the Institut Pasteur in Tunis (IPT), details the crucial role that the IPT plays in the development of the Tunisian health sector, his wide-ranging responsibilities as general manager, the increasing importance of building new partnerships between the private and public sectors, and the Institute’s ambition…
See our Cookie Privacy Policy Here
